VAERS reports by lot

Pfizer COVID-19 lot HD9835: VAERS reports

111 VAERS reports list lot HD9835 as a Pfizer COVID-19 vaccine, received between 2023-09-23 and 2024-10-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
111
Reports
7%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5920%
Cardiac / Cardiovascular5820%
Neurological3713%
Musculoskeletal3412%
Injection-site / Local reaction2910%
Gastrointestinal228%
Respiratory145%
Allergic / Anaphylactic135%
Dermatological (non-injection-site)135%
Autoimmune / Immune-mediated41%
Thrombotic / Hematological31%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California14
North Carolina9
Ohio7
Texas7
Florida6
New York6
Tennessee6
New Jersey5
Illinois4
Colorado4
Michigan4
Virginia3

Reports by month received

2023-0911
2023-1039
2023-118
2023-1217
2024-0114
2024-024
2024-036
2024-041
2024-052
2024-066
2024-103

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.